UNIVERSITY OF ROCHESTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1850-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.rochester.edu
Prophylactic Tamsulosin Use for Prevention of Post-Operative Urinary Retention
Not Applicable
Terminated
- Conditions
- Post-Operative Urinary Retention
- Interventions
- Drug: TamsulosinOther: Education
- First Posted Date
- 2016-02-18
- Last Posted Date
- 2019-01-23
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 5
- Registration Number
- NCT02684344
- Locations
- 🇺🇸
University of Rochester, Rochester, New York, United States
NIR Fluorescence Imaging of Lymphatic Transport Using ICG
Phase 1
Completed
- Conditions
- Rheumatoid Arthritis
- Interventions
- Drug: Indocyanine GreenDevice: MultiSpectral Imaging System
- First Posted Date
- 2016-02-11
- Last Posted Date
- 2022-10-18
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 23
- Registration Number
- NCT02680067
- Locations
- 🇺🇸
University of Rochester, Rochester, New York, United States
Aromatherapy for Chemotherapy-induced Symptoms
Early Phase 1
Terminated
- Conditions
- Chemotherapy Symptoms
- Interventions
- First Posted Date
- 2016-02-02
- Last Posted Date
- 2019-01-24
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 31
- Registration Number
- NCT02670941
- Locations
- 🇺🇸
University of Rochester Medical Center, Wilmot Canter Center, Rochester, New York, United States
URMC Related Haplo-identical Donor BMT
Phase 1
Completed
- Conditions
- Immune DeficienciesSolid TumorsMyelofibrosisMultiple MyelomaLymphomaHematological Disease
- Interventions
- Radiation: Total Body Irradiation 1200 cGyDrug: FludarabineDrug: Pre-Stem Cell Infusion CyclophosphamideDrug: MelphalanProcedure: Stem Cell InfusionDrug: Pre-Stem Cell Infusion MesnaDrug: Post-Stem Cell Infusion CyclophosphamideDrug: BusulfanDrug: Post-Stem Cell Infusion MesnaDrug: Thiotepa
- First Posted Date
- 2016-01-21
- Last Posted Date
- 2021-11-03
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 74
- Registration Number
- NCT02660281
- Locations
- 🇺🇸
Wilmot Cancer Institute, Rochester, New York, United States
The Role of Microparticles as a Biomarker
Withdrawn
- Conditions
- MicroparticlesAtypical Hemolytic Uremic SyndromeThrombotic Thrombocytopenic PurpuraMicroangiopathic Hemolytic Anemia
- First Posted Date
- 2015-12-10
- Last Posted Date
- 2019-02-19
- Lead Sponsor
- University of Rochester
- Registration Number
- NCT02626663
- Locations
- 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States
Enzalutamide for Bladder Cancer Chemoprevention
- First Posted Date
- 2015-11-16
- Last Posted Date
- 2018-10-03
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 1
- Registration Number
- NCT02605863
- Locations
- 🇺🇸
University of Rochester, Rochester, New York, United States
Mexiletine for Muscle Cramps in Charcot Marie Tooth Disease
- First Posted Date
- 2015-09-28
- Last Posted Date
- 2018-03-26
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 4
- Registration Number
- NCT02561702
- Locations
- 🇺🇸
University of Rochester, Rochester, New York, United States
Vision-based Speed of Processing Cognitive Training and Mild Cognitive Impairment
Not Applicable
Completed
- Conditions
- Mild Cognitive Impairment
- Interventions
- Behavioral: Vision-based speed of processing trainingBehavioral: Mental leisure activities
- First Posted Date
- 2015-09-24
- Last Posted Date
- 2019-10-02
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 84
- Registration Number
- NCT02559063
- Locations
- 🇺🇸
University of Rochester Memory Care Program, Rochester, New York, United States
Influenza Immunity in Children
Not Applicable
Completed
- Conditions
- Influenza
- Interventions
- Other: Natural influenza infectionBiological: Seasonal IIV 0.25 mL doseBiological: Seasonal IIV 0.5 mL dose
- First Posted Date
- 2015-09-24
- Last Posted Date
- 2021-09-02
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 134
- Registration Number
- NCT02559505
- Locations
- 🇺🇸
University of Rochester, Rochester, New York, United States
Optical Coherence Tomography of Tear Film Dynamics In-Vivo
Not Applicable
Completed
- Conditions
- Dry Eye Disease
- Interventions
- Other: Optical Coherence Tomography
- First Posted Date
- 2015-09-18
- Last Posted Date
- 2018-04-20
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 2
- Registration Number
- NCT02554084
- Locations
- 🇺🇸
University of Rochester, Rochester, New York, United States
© Copyright 2025. All Rights Reserved by MedPath